![Medscape on Twitter: "Could steroid treatment speed recovery from infliximab-induced liver injury? https://t.co/UaHvCrehNh https://t.co/JpCOI5hPhT" / Twitter Medscape on Twitter: "Could steroid treatment speed recovery from infliximab-induced liver injury? https://t.co/UaHvCrehNh https://t.co/JpCOI5hPhT" / Twitter](https://pbs.twimg.com/media/FAwaYkjWEAAXKXM.jpg)
Medscape on Twitter: "Could steroid treatment speed recovery from infliximab-induced liver injury? https://t.co/UaHvCrehNh https://t.co/JpCOI5hPhT" / Twitter
![Infliximab launch is milestone in development of UK biosimilars industry - European Pharmaceutical Review Infliximab launch is milestone in development of UK biosimilars industry - European Pharmaceutical Review](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/many-pills.jpg)
Infliximab launch is milestone in development of UK biosimilars industry - European Pharmaceutical Review
![Inflixamab (Remicade) - Leading Manufacturer and Exporter of Pseudoephedrine hcl and Tablets. Contract Manufacturing for International Pharma Companies Inflixamab (Remicade) - Leading Manufacturer and Exporter of Pseudoephedrine hcl and Tablets. Contract Manufacturing for International Pharma Companies](https://www.delphispharma.com/wp-content/uploads/2018/08/Inflixamab.jpg)
Inflixamab (Remicade) - Leading Manufacturer and Exporter of Pseudoephedrine hcl and Tablets. Contract Manufacturing for International Pharma Companies
![Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S177322472100232X-ga1.jpg)
Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect
![Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial - The Lancet Gastroenterology & Hepatology Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/2062546446/2064765368/gr1.gif)
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial - The Lancet Gastroenterology & Hepatology
![Pharmaceutics | Free Full-Text | Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process Pharmaceutics | Free Full-Text | Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process](https://www.mdpi.com/pharmaceutics/pharmaceutics-11-00428/article_deploy/html/images/pharmaceutics-11-00428-g001-550.jpg)